Publications by authors named "P Maslak"

Claim this Profile
A
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.
Theresa Hahn, Megan M Herr, Paul K Wallace, Yali Zhang, Shernan Holtan, Peter Maslak

Leuk Lymphoma· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Megan M Herr, Sophia R Balderman, Paul K Wallace, Yali Zhang, Joseph D Tario, Peter Maslak

Transplant Cell Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.
Giovanna Melica, Elaina Preston, Meighan Palazzo, Kenneth Seier, Florent Malard, Peter Maslak

Bone Marrow Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Activity of Extracts from Differently Produced Blueberry Fruits in Inhibiting Proliferation and Inducing Apoptosis of HT-29 Cells.
Ewelina Kiernozek, Piotr Maslak, Ewa Kozlowska, Ingeborga Jarzyna, Dominika Średnicka-Tober

Foods· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, Neeta Pandit-Taskar, Mark G Frattini, Peter G Maslak

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis